4/A//SEC Filing
Dalal Anupam 4/A
Accession 0000899243-21-034635
CIK 0001422142other
Filed
Aug 30, 8:00 PM ET
Accepted
Aug 31, 7:52 PM ET
Size
5.9 KB
Accession
0000899243-21-034635
Insider Transaction Report
Form 4/AAmended
Dalal Anupam
Director
Transactions
- Purchase
Common Stock
2021-08-26$13.08/sh+1,529,402$19,999,990→ 1,529,402 total(indirect: See footnote)
Footnotes (2)
- [F1]Consists of (i) 1,284,698 shares held by Acuta Capital Fund, LP ("Acuta Capital") and (ii) 244,704 shares held by Acuta Opportunity Fund, LP. ("Acuta Opportunity Fund"). Acuta Capital Partners, LLC ("Acuta Partners") is the general partner of each of Acuta Capital and Acuta Opportunity Fund. The Reporting Person is the Chief Investment Officer and Managing Member of Acuta Partners. The Reporting Person has voting and investment authority over all of the shares held by each of Acuta Capital and Acuta Opportunity Fund. Each of Acuta Partners and the Reporting Person disclaim beneficial ownership of the shares of common stock held by each of Acuta Capital and Acuta Opportunity Fund except to the extent of their pecuniary interest therein.
- [F2]This amendment is filed to correct footnote (1) included in the Form 4 filed August 30, 2021.
Documents
Issuer
Aadi Bioscience, Inc.
CIK 0001422142
Entity typeother
Related Parties
1- filerCIK 0001602474
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 30, 8:00 PM ET
- Accepted
- Aug 31, 7:52 PM ET
- Size
- 5.9 KB